Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) Net Margin: 2024-2025

Historic Net Margin for Prime Medicine (PRME) over the last 2 years, with Sep 2025 value amounting to -4,129.14%.

  • Prime Medicine's Net Margin rose 2099909.00% to -4,129.14% in Q3 2025 from the same period last year, while for Sep 2025 it was -3,301.64%, marking a year-over-year change of. This contributed to the annual value of -6,566.61% for FY2024, which is N/A change from last year.
  • Per Prime Medicine's latest filing, its Net Margin stood at -4,129.14% for Q3 2025, which was up 12.46% from -4,716.68% recorded in Q2 2025.
  • In the past 5 years, Prime Medicine's Net Margin registered a high of -1,936.60% during Q4 2024, and its lowest value of -25,128.23% during Q3 2024.
  • Moreover, its 2-year median value for Net Margin was -4,422.91% (2025), whereas its average is -7,870.40%.
  • Data for Prime Medicine's Net Margin shows a peak YoY surged of 2,099,909bps (in 2025) over the last 5 years.
  • Over the past 2 years, Prime Medicine's Net Margin (Quarterly) stood at -1,936.60% in 2024, then soared by 2,099,909bps to -4,129.14% in 2025.
  • Its last three reported values are -4,129.14% in Q3 2025, -4,716.68% for Q2 2025, and -3,568.78% during Q1 2025.